The PE Ratio as of December 2025 (TTM) for Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) is 89.44

According to Biocytogen Pharmaceuticals (Beijing) Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 89.44. This represents a change of 999.17% compared to the average of 8.14 of the last 4 quarters.

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) Historical PE Ratio (quarterly & annually)

How has 2315.HK PE Ratio performed in the past?

The mean historical PE Ratio of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. over the last ten years is 7.59. The current 89.44 PE Ratio has changed 117.68% with respect to the historical average. Over the past ten years (40 quarters), 2315.HK's PE Ratio was at its highest in in the June 2025 quarter at 42.36. The PE Ratio was at its lowest in in the June 2024 quarter at -13.98.

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) Average PE Ratio

How has 2315.HK PE Ratio performed in the past?

The current PE Ratio of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) PE Ratio vs. Peers

How is 2315.HK’s PE Ratio compared to its peers?

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.’s PE Ratio is greater than Alphamab Oncology (46.42), greater than Shanghai Haohai Biological Technology Co., Ltd. (29.01), greater than Lepu Biopharma Co., Ltd. (-62.91), less than Nanjing Leads Biolabs Co Ltd (0), greater than HBM Holdings Limited (38.38), greater than Abbisko Cayman Limited (55.38), greater than Angelalign Technology Inc. (54.98), greater than CARsgen Therapeutics Holdings Limited (-22.88), greater than Beijing Chunlizhengda Medical Instruments Co., Ltd. (36.32), greater than Ascletis Pharma Inc. (-46.15),

Build a custom stock screener for Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biocytogen Pharmaceuticals (Beijing) Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Biocytogen Pharmaceuticals (Beijing) Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.